Indications and Purposes
| 1 Indications And Usage Cosentyx Is A Human Interleukin-17a Antagonist Indicated For The Treatment Of: Moderate To Severe Plaque Psoriasis In Adult Patients Who Are Candidates For Systemic Therapy Or Phototherapy ( 1.1 ) Adults With Active Psoriatic Arthritis (Psa) ( 1.2 ) Adults With Active Ankylosing Spondylitis (As) ( 1.3 ) Adults With Active Non-Radiographic Axial Spondyloarthritis (Nr-Axspa) With Objective Signs Of Inflammation ( 1.4 ) 1.1 Plaque Psoriasis Cosentyx ® Is Indicated For The Treatment Of Moderate To Severe Plaque Psoriasis In Adult Patients Who Are Candidates For Systemic Therapy Or Phototherapy. 1.2 Psoriatic Arthritis Cosentyx Is Indicated For The Treatment Of Adult Patients With Active Psoriatic Arthritis. 1.3 Ankylosing Spondylitis Cosentyx Is Indicated For The Treatment Of Adult Patients With Active Ankylosing Spondylitis. 1.4 Non-Radiographic Axial Spondyloarthritis Cosentyx Is Indicated For The Treatment Of Adult Patients With Active Non-Radiographic Axial Spondyloarthritis (Nr-Axspa) With Objective Signs Of Inflammation. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Secukinumab |